Skip to main content
. Author manuscript; available in PMC: 2012 Apr 11.
Published in final edited form as: Transplantation. 2011 Mar;91(6):652–656. doi: 10.1097/TP.0b013e31820ae4ac

Figure 2.

Figure 2

Estimated in vitro intrinsic clearance (CLint) of everolimus (a) and tacrolimus (b) metabolism by human recombinant cytochrome P450 (rhCYP) 3A4 and 3A5. Grayed box represents the activity of rhCYP co-expressed with cytochrome b5 and hatched box the activity of rhCYP without cytochrome b5. The CLint were estimated from tacrolimus and everolimus in vitro metabolic half-lives as described in the materials and methods section. Results are derived from duplicate experiments.